modafinil has been researched along with selegiline in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Annane, D; Barnes, PR; Miller, RG; Moore, DH | 1 |
Thorpy, M | 1 |
Botrè, F; Colamonici, C; Strano-Rossi, S | 1 |
3 review(s) available for modafinil and selegiline
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.
Topics: Benzhydryl Compounds; Disorders of Excessive Somnolence; Humans; Modafinil; Monoamine Oxidase Inhibitors; Myotonic Dystrophy; Psychotropic Drugs; Randomized Controlled Trials as Topic; Selegiline | 2006 |
Therapeutic advances in narcolepsy.
Topics: Benzhydryl Compounds; Cataplexy; Central Nervous System Stimulants; Humans; Immunotherapy; Methylphenidate; Modafinil; Narcolepsy; Quality of Life; Selective Serotonin Reuptake Inhibitors; Selegiline; Sodium Oxybate | 2007 |
4 other study(ies) available for modafinil and selegiline
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Parallel analysis of stimulants in saliva and urine by gas chromatography/mass spectrometry: perspectives for "in competition" anti-doping analysis.
Topics: Adult; Aminobutyrates; Benzhydryl Compounds; Calibration; Central Nervous System Stimulants; Cocaine; Crotonates; Doping in Sports; Ephedrine; Female; Gas Chromatography-Mass Spectrometry; Humans; Modafinil; Saliva; Selegiline; Substance Abuse Detection; Time Factors | 2008 |